NINGBO INNO PHARMCHEM CO.,LTD. highlights N-Boc-D-Serine (CAS 6368-20-3) as a cornerstone intermediate in the advancement of pharmaceutical development. This high-purity chiral amino acid derivative is essential for the synthesis of sophisticated drug molecules, playing a key role in therapeutic areas such as neurology and peptide-based treatments. As a leading pharmaceutical intermediates supplier, we are committed to providing the quality materials that drive innovation in medicine.

The compound, scientifically known as (2R)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid, is recognized for its utility in precisely controlled chemical reactions. Its primary claim to fame is its function as an N-Boc-D-Serine intermediate for Lacosamide synthesis. Lacosamide, an effective treatment for partial-onset seizures and diabetic neuropathic pain, relies on the stereochemical purity provided by N-Boc-D-Serine. This makes the integrity of CAS 6368-20-3 synthesis a critical factor for manufacturers.

The value of N-Boc-D-Serine also extends into the realm of peptide chemistry. As a protected amino acid, it facilitates the controlled assembly of peptide chains, which are integral to many new drug candidates and therapeutic peptides. The availability of a high purity chiral amino acid derivative like this one is vital for researchers and manufacturers working on these cutting-edge projects. NINGBO INNO PHARMCHEM CO.,LTD. ensures that when you buy N-Boc-D-Serine online, you receive a product that meets stringent standards for assay (≥98.0%), impurity profiles, and specific rotation, all crucial for reproducible results in peptide synthesis.

The physical form of N-Boc-D-Serine as a white to off-white powder, with a defined melting point and density, are important considerations for handling and formulation. Our company's dedication to quality assurance means that every batch of N-Boc-D-Serine adheres to these exacting specifications. By providing this fundamental intermediate, NINGBO INNO PHARMCHEM CO.,LTD. supports the pharmaceutical industry's ongoing efforts to develop safer, more effective treatments and advance scientific understanding.